Immunoprophylaxis and therapy of grafted rat colonic carcinoma.
Open Access
- 1 March 1977
- Vol. 18 (3), 232-235
- https://doi.org/10.1136/gut.18.3.232
Abstract
Two independent lines of chemically-induced colonic carcinoma, serially graftable in syngeneic rats, have been used to investigate the effects of immunoprophylaxis and immunotherapy. Rats were immunised by various procedures, including BCG, irradiated tumour grafts, and cancer cells treated by mitomycin and neuraminidase. A partial inhibition of tumour growth was observed in one of the four protocols. On the other hand, a significant enhancement of tumour growth was obtained in two other experiments.This publication has 19 references indexed in Scilit:
- Suitability of Rat Mammary Adenocarcinoma 13762 as a Model for BCG Immunotherapy2JNCI Journal of the National Cancer Institute, 1976
- PROLONGATION OF POSTOPERATIVE DISEASE-FREE INTERVAL AND SURVIVAL IN HUMAN COLORECTAL CANCER BY B.C.G. OR B.C.G. PLUS 5-FLUOROURACILThe Lancet, 1976
- Sequential Studies of Serum Blocking Activity in Rats Bearing Chemically Induced Primary Bowel Tumors2JNCI Journal of the National Cancer Institute, 1975
- Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.1974
- Cell-mediated and humoral immune reactions to human tumoursInternational Journal of Cancer, 1973
- An experimental model for cancer of the colon and rectum. Intestinal carcinoma induced in the rat 1,2-dimethylhydrazine.1973
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- SKIN-REACTIVE SOLUBLE ANTIGEN FROM INTESTINAL CANCER-CELL-MEMBRANES AND RELATIONSHIP TO CARCINOEMBRYONIC ANTIGENSThe Lancet, 1970
- Tumour-specific antigenicity of aminoazo-dye-induced rat hepatomasInternational Journal of Cancer, 1967